Preferred Name |
sodium polystyrene sulfonate 15000 MG Powder for Oral Suspension |
|
Synonyms |
sodium polystyrene sulfonate 15 to 60 GM Powder for Oral Suspension |
|
ID |
http://purl.bioontology.org/ontology/RXNORM/2101899 |
|
altLabel |
sodium polystyrene sulfonate 15 to 60 GM Powder for Oral Suspension sodium polystyrene sulfonate 15 GM Powder for Suspension sodium polystyrene sulfonate 30 to 50 GM Powder for Rectal Suspension sodium polystyrene sulfonate 4.1 MEQ in 1 GM Powder for Oral Suspension |
|
Consists of | ||
cui |
C4721913 |
|
Has dose form | ||
isa |
http://purl.bioontology.org/ontology/RXNORM/1159945 |
|
NDC |
62135034053 42806001394 62135034011 11534016615 17856002402 10702003615 50488500101 63629203101 17856002404 17856002403 10702003645 13811065653 63629239001 17856083101 70166071210 10135014614 62135034062 10135014617 69315020515 24658076016 51293083197 69315020545 11534016644 46287001216 17856002401 63629885001 11534016616 42808050016 42806001396 62250066023 63629884901 |
|
notation |
2101899 |
|
prefLabel |
sodium polystyrene sulfonate 15000 MG Powder for Oral Suspension |
|
RXAUI |
10774868 12543120 10774867 12350667 10774866 |
|
RXCUI |
2101899 |
|
RXN AI |
{2101896} 56512 |
|
RXN AM |
{2101896} 56512 |
|
RXN AVAILABLE STRENGTH |
15000 MG |
|
RXN Boss From |
{2101896} AI |
|
RXN HUMAN DRUG |
US |
|
tui |
T200 |
Delete | Mapping To | Ontology | Source |
---|---|---|---|
http://purl.bioontology.org/ontology/VANDF/4038298 | VANDF | CUI | |
http://purl.bioontology.org/ontology/VANDF/4004264 | VANDF | CUI | |
http://purl.bioontology.org/ontology/NDDF/001194 | NDDF | CUI | |
http://purl.obolibrary.org/obo/DRON_00835267 | PDRO | LOOM | |
http://purl.obolibrary.org/obo/DRON_00835267 | DRON | LOOM |